688535 华海诚科
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.7881.5103.8784.50011.412
总资产报酬率 ROA (%)1.2781.0633.0433.6458.228
投入资产回报率 ROIC (%)1.4111.1753.4394.33811.392

边际利润分析
销售毛利率 (%)30.33826.65625.63426.88027.007
营业利润率 (%)9.3214.53612.19111.04113.715
息税前利润/营业总收入 (%)10.7395.94713.77011.98314.260
净利润/营业总收入 (%)8.4505.24312.04211.18413.596

收益指标分析
经营活动净收益/利润总额(%)74.759-59.55529.26046.38884.973
价值变动净收益/利润总额(%)14.015123.19145.93141.1813.729
营业外收支净额/利润总额(%)-3.100-3.5917.7127.5521.184

偿债能力分析
流动比率 (X)3.8174.3641.8741.8592.981
速动比率 (X)3.0583.8391.4431.3962.409
资产负债率 (%)25.80931.17125.90116.51425.089
带息债务/全部投入资本 (%)14.70521.90514.5161.983-2.802
股东权益/带息债务 (%)560.049344.959572.5234,797.307-3,568.677
股东权益/负债合计 (%)287.463220.807286.010505.565298.585
利息保障倍数 (X)6.3263.79424.602299.69637.429

营运能力分析
应收账款周转天数 (天)123.790175.587137.360151.918136.758
存货周转天数 (天)104.651139.644118.638127.137110.099